Cite
MLA Citation
Elisabeth A. Lasater et al.. “Targeting MCL‐1 and BCL‐2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non‐Hodgkin lymphoma: Results from preclinical models and a Phase Ib study.” American journal of hematology, vol. 98, no. 3, 2023, pp. 449–463. http://access.bl.uk/ark:/81055/vdc_100177578359.0x00004b